ATT-01

N/A

Report date: 2025/06/03 16:45:45
NMEFirst In Class

Base Information

Drug NameATT-01
Drug Alias NameATT-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein phosphatase 2A activators
TargetsProtein phosphatase 2A
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAttivare Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAttivare Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A